Detalhe da pesquisa
1.
Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells.
J Allergy Clin Immunol
; 152(1): 56-67, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001649
2.
Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children.
BMJ Open Respir Res
; 9(1)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198442
3.
Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication.
Sci Rep
; 12(1): 6972, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484173
4.
IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2.
J Exp Med
; 219(9)2022 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35938988
5.
Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures.
Methods Protoc
; 4(1)2021 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33430421
6.
Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication.
bioRxiv
; 2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845445
7.
Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.
Front Pharmacol
; 12: 765951, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34867390
8.
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
bioRxiv
; 2021 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851164
9.
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Elife
; 102021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874007
10.
Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2.
J Exp Med
; 219(9)2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036783